Trial intelligence / Profile preview

Locally delivered metformin for periodontitis

NCT06204185Completed

Sponsor
Ain Shams University
Start
Feb 2019
Primary completion
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of metformin 1% gel in periodontitis (2 arms), sponsored by Ain Shams University. Primary endpoints: Receptor Activator of Nuclear Factor Kappa-B Ligand at 1 month and Osteoprotegrin at 1 month. Started Feb 2019; status: completed.

02

Drugs

metformin 1% gel
03

Conditions

periodontitis

Beyond the preview

Go deeper on NCT06204185.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06204185.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call